Posted in | News | Silver | Mining Business

Americas Gold and Silver Provides an Update to the Re-Opening of Its Cosalá Operations

Americas Gold and Silver Corporation ("Americas" or the "Company") is pleased to provide an update to the re-opening of the Company's Cosalá Operations.

The Los Braceros plant has returned to nameplate production with a steady source of feed from a combination of existing stockpiled ore and new production from the mine. San Rafael mine production continues to ramp-up and does not represent a bottleneck to mill production.

Initial production will focus on maximizing near-term free cash flow by mining high-grade zinc-silver areas of the Main Zone which were fully developed prior to the illegal blockade. Over the course of the next six months, the mine will continue development into the Upper Zone, which carries silver grades approximately 5-6 times higher than the Main Zone. Mining the silver-rich areas of the Cosalá Operations is expected to significantly increase silver production to over 2.5 million ounces of silver per year.

"I am pleased to see that the Los Braceros plant has efficiently returned to nameplate production after a brief ramp-up period," stated Americas Gold and Silver President & CEO Darren Blasutti. "We are currently processing high-grade material through the mill which should positively impact metal production, revenue and cashflow through the balance of the year and continue into 2022. I would like to thank our work force for all their efforts in an efficient and effective return to operations. I am confident the Company will have a good start to 2022 with the re-opening of the Cosalá Operations and the strong current metal prices."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.